Remimazolam versus propofol in combination with esketamine for surgical abortion: A double‐blind ran...
Remimazolam versus propofol in combination with esketamine for surgical abortion: A double‐blind randomized controlled trial
About this item
Full title
Author / Creator
Yue, Linli , Ma, Xiaoling , Li, Na , Chen, Jing , Wang, Jun , Wan, Zhenzhen and Yang, Lin
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Remimazolam is a new benzodiazepine with a short half‐life, good efficacy, and safety profiles in general anesthesia. Combining esketamine with propofol (P + E) could reduce propofol consumption and injection pain. It is, however, unclear if a low dose of remimazolam co‐administrated with esketamine (R + E) is comparable to the increasingly used P...
Alternative Titles
Full title
Remimazolam versus propofol in combination with esketamine for surgical abortion: A double‐blind randomized controlled trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_fa5cc27d3f3c475386ef7d03727fed14
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa5cc27d3f3c475386ef7d03727fed14
Other Identifiers
ISSN
1752-8054,1752-8062
E-ISSN
1752-8062
DOI
10.1111/cts.13572
